Subscribe
COVID-19 Miniseries Episode 10: How to Mitigate Drug-Induced Sudden Cardiac Death From Hydroxychloroquine

Mayo Clinic Talks

COVID-19 Miniseries Episode 10: How to Mitigate Drug-Induced Sudden Cardiac Death From Hydroxychloroquine

This episode was recorded on April 3, 2020Claim credit here: https://ce.mayo.edu/covid19podcastGuest:  Michael J. Ackerman, M.D., Ph.D. (@MJAckermanMDPhD)Host: Amit K. Ghosh, M.D., M.B.A. (@AmitGhosh006)The administration of hydroxychloroquine and az...
April 3, 2020
ADVERTISEMENT
WP Engine Wordpress Hosting

COVID-19 Miniseries Episode 10: How to Mitigate Drug-Induced Sudden Cardiac Death From Hydroxychloroquine

This episode was recorded on April 3, 2020

Claim credit here: https://ce.mayo.edu/covid19podcast

Guest:  Michael J. Ackerman, M.D., Ph.D. (@MJAckermanMDPhD)

Host: Amit K. Ghosh, M.D., M.B.A. (@AmitGhosh006)

The administration of hydroxychloroquine and azithromycin, along with other very common medications could result in drug-induced sudden cardiac death caused by drug-induced QT prolongation, in some patients. In order to avoid the wrong medication, for the wrong patient, at the wrong time, Dr. Michael Ackerman shares how to assess your patient’s risk, how to find and measure their QTc value, and neutralize the threat.

Deeper Dive:

Giudicessi JR, Noseworthy PA, Friedman PA, Ackerman MJ. Urgent guidance for navigating and circumventing the QTc prolonging and torsadogenic potential of possible pharmacotherapies for COVID-19 [published online ahead of print March 25, 2020]. Mayo Clin Proc. https://doi.org/10.1016/j.mayocp.2020.03.024.

Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

ADVERTISEMENT
WP Engine Wordpress Hosting

You may also like

The Latest Health Podcasts. Delivered to Your Inbox.

Proudly supported by:

cover
Javier Lozano - Market-Creating Innovation for Diabetes Care an inspiring conversation with Javier Lozano, Founder and CEO of Clínicas del Azúcar, a growing chain of "one-stop shops" for diabetes care in Mexico.